Insulin Action Gene Regulation

  • Calum Sutherland
  • Richard M. O’ Brien
  • Daryl K. Granner


Insulin regulates metabolism by altering the concentration of critical proteins or by inducing post-translational modifications of preexisting molecules. The latter represents a well-recognized action of insulin, and it has been extensively studied for many years.1, 2, 3By contrast, it is only recently that considerable advances have been made in understanding several aspects of insulin-regulated gene expression.


Insulin Action Insulin Receptor Substrate Fatty Acid Synthetase H4IIE Cell Insulin Regulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Denton RM. Early events in insulin actions. Adv Cyclic Nucleotide Protein Phosphorylation Res 1986; 20:293–341.PubMedGoogle Scholar
  2. 2.
    Cohen P, Campbell DG, Dent P et al. Dissection of the protein kinase cascades involved in insulin and nerve growth factor action. Biochem Soc Trans 1992; 20:671–74.PubMedGoogle Scholar
  3. 3.
    Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cel Biochem 1998; 182:31–48.Google Scholar
  4. 4.
    O’Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev 1996; 76:1109–61.Google Scholar
  5. 5.
    Sutherland C, O’Brien RM, Granner DK. Genetic regulation of glucose metabolism. In: Jefferson LS, Cherrington AD, eds. Handbook of Physiology. Oxford University Press, 2003:707–34.Google Scholar
  6. 6.
    Granner DK, Pilkis S. The genes of hepatic glucose metabolism. J Biol Chem 1990; 265:10173–78.PubMedGoogle Scholar
  7. 7.
    Iynedjian PB, Jotterand D, Nouspikel T et al. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem 1989; 264:21824–29.PubMedGoogle Scholar
  8. 8.
    Unger RH. Diabetic hyperglycemia: Link to impaired glucose transport in pancreatic b cells. Science 1991; 251:1200–05.PubMedGoogle Scholar
  9. 9.
    Permutt MA, Chiu KC, Tanizawa Y. Glucokinase and NIDDM. A candidate gene that paid off. Diabetes 41 1992; 11(1367–1372).PubMedGoogle Scholar
  10. 10.
    Granner DK, O’Brien RM. Molecular physiology and genetics of NIDDM. Diabetes Care 1992; 15(3):369–95.PubMedGoogle Scholar
  11. 11.
    Valera A, Pujol A, Pelegrin M et al. Transgenic mice overexpressing PEPCK develop NIDDM. Proc Natl Acad Sci 1994; 91:9151–54.PubMedGoogle Scholar
  12. 12.
    Kahn CR. Insulin action, Diabetogenes and the cause of Type II Diabetes. Diabetes 1994; 43:1066–84.PubMedGoogle Scholar
  13. 13.
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of TNF-a: Direct role in obesity-linked insulin resistance. Science 1993; 259:87–91.PubMedGoogle Scholar
  14. 14.
    Maddux BA, Sbraccia P, Kumakura S et al. Membrane glycoprotein PC-1 and insulin resistance in noninsulin-dependent DM. Nature 1995; 373:448–51.PubMedGoogle Scholar
  15. 15.
    Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001; 24(3):588–97.PubMedGoogle Scholar
  16. 16.
    Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13(1): 18–23.PubMedGoogle Scholar
  17. 17.
    Tonks NK. PTP1B: From sidelines to the front lines! FEBS Letters 2003; 546(1):140–8.PubMedGoogle Scholar
  18. 18.
    Kahn CR, White MF. The Insulin receptor and the molecular mechanism of insulin action. J Clin Invest 1988; 82(4):1151–56.PubMedGoogle Scholar
  19. 19.
    White MF, Kahn CR. The insulin signalling system. J Biol Chem 1994; 269(1):1–4.PubMedGoogle Scholar
  20. 20.
    White MF. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 1998; 182:3–11.PubMedGoogle Scholar
  21. 21.
    Uchida T, Myers Jr MG, White MF. IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis. Mol Cell Biol 2000; 20(1):126–38.PubMedGoogle Scholar
  22. 22.
    Pelicci G, Lanfrancone L, Grignani F et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70(1):93–104.PubMedGoogle Scholar
  23. 23.
    Yamanashi Y, Baltimore D. Identification of the Abl-and rasGAP-associated 62 kDa protein as a docking protein. Dok Cell 1997; 88(2):205–11.Google Scholar
  24. 24.
    Wick MJ, Dong LQ, Hu D et al. Insulin-receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GAP and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J Biol Chem 2001; 278(46):42843–50.Google Scholar
  25. 25.
    Pawson T. Protein modules and insulin signaling networks. Nature 1995; 373:573–80.PubMedGoogle Scholar
  26. 26.
    Kaburagi Y, Yamauchi T, Yamamoto-Honda R et al. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family. Endocr J 1999; 46(Suppl):S25–34.PubMedGoogle Scholar
  27. 27.
    Cantley LC. The PI3-kinase pathway. Science 2002; 296:1655–57.PubMedGoogle Scholar
  28. 28.
    Kapeller R, Cantley LC. PI3-kinase. Bioessays 1994; 16(8):565–76.PubMedGoogle Scholar
  29. 29.
    Vanhaesebroeck B, Leevers SJ, Panayotou G et al. Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem Sci 1997; 22(7):267–72.PubMedGoogle Scholar
  30. 30.
    Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem J 1998; 333(3):471–90.PubMedGoogle Scholar
  31. 31.
    Stephens LR, Hughes KT, Irvine RF. Pathway of phosphatidylinositol(3,4,5)-triphosphate synthesis in activated neutrophils. Nature 1991; 351(6321):33–39.PubMedGoogle Scholar
  32. 32.
    Hawkins PT, Jackson TR, Stephens LR. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature 1992; 358(6382):157–59.PubMedGoogle Scholar
  33. 33.
    Leslie NR, Biondi RM, Alessi DR. Pi-regulated kinases and PI phosphatases. Chem Rev 2001; 101(8):2365–80.PubMedGoogle Scholar
  34. 34.
    Vanhaesebroeck B, Leevers SJ, Ahmadi K et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70:535–602.PubMedGoogle Scholar
  35. 35.
    Sutherland C, O’Brien RM, Granner DK. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of Phosphoenolpyruvate Carboxykinase gene expression by insulin. J Biol Chem 1995; 270(26):15501–06.PubMedGoogle Scholar
  36. 36.
    Gabbay RA, Sutherland C, Gnudi L et al. Insulin regulation of PEPCK gene expression does not require activation of the Ras/MAP kinase signaling pathway. J Biol Chem 1996; 271(4):1890–97.PubMedGoogle Scholar
  37. 37.
    Sutherland C, Waltner-Law M, Gnudi L et al. Activation of the Ras-MAP Kinase-RSK pathway is not required for the repression of PEPCK gene transcription by insulin. J Biol Chem 1998; 273(6):3198–204.PubMedGoogle Scholar
  38. 38.
    Alessi DR, Downes CP. The role of PI3-kinase in insulin action. Biochim Biophys Acta 1998; 1436:151–64.PubMedGoogle Scholar
  39. 39.
    Williams MR, Arthur JS, Balendran A et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 2000; 10(8):439–48.PubMedGoogle Scholar
  40. 40.
    Chung J, Kuo CJ, Crabtree GR et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kDa S6 protein kinases. Cell 1992; 69:1227–36.PubMedGoogle Scholar
  41. 41.
    Sturgill TW, Ray LB, Erikson E et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988; 334:715–18.PubMedGoogle Scholar
  42. 42.
    Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278(5346):2075–80.PubMedGoogle Scholar
  43. 43.
    Moodie SA, Willumsen BM, Weber MJ et al. Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 1993; 260(5114):1658–61.PubMedGoogle Scholar
  44. 44.
    Stokoe D, Macdonald SG, Cadwallader K et al. Activation of Raf as a result of recruitment to the plasma membrane. Science 1994; 264(5164):1463–7.PubMedGoogle Scholar
  45. 45.
    Kyriakis JM, App H, Zhang XF et al. Raf-1 activates MAP kinase-kinase. Nature 1992; 358(6385):417–21.PubMedGoogle Scholar
  46. 46.
    Dent P, Haser W, Haystead TA et al. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 1992; 257(5075):1404–7.PubMedGoogle Scholar
  47. 47.
    Zheng CF, Guan KL. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J 1994; 13(5):1123–31.PubMedGoogle Scholar
  48. 48.
    Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410:37–40.PubMedGoogle Scholar
  49. 49.
    Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends in Cell Biology 1997; 7:353–61.PubMedGoogle Scholar
  50. 50.
    Lee YH, Giraud J, Davis RJ et al. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 2003; 278(5):2896–902.PubMedGoogle Scholar
  51. 51.
    Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420(6913):333–36.PubMedGoogle Scholar
  52. 52.
    Pearson G, Robinson F, Beers-Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocrin Rev 2001; 22:153–83.Google Scholar
  53. 53.
    Parekh DB, Ziegler W, Parker PJ. Multiple pathways control PKC phosphorylation. EMBO J 2000; 19(4):496–503.PubMedGoogle Scholar
  54. 54.
    Messina JL, Weinstock RS. Evidence for diverse roles of PKC in the inhibition of gene expression by insulin. Endocrinology 1994; 135(6):2327–34.PubMedGoogle Scholar
  55. 55.
    Toker A, Meyer M, Reddy KK et al. Activation of PKC family members by the novel polyphosphoinositides PI-3,4-P2 and PI-3,4,5-P3. J Biol Chem 1994; 269(51):32358–67.PubMedGoogle Scholar
  56. 56.
    Bandyopadhay G, Standaert ML, Zhao L et al. Activation of Protein Kinase C (α β and ξ) by Insulin in 3T3/L1 cells. J Biol Chem 1997; 272(4):2551–58.Google Scholar
  57. 57.
    Le Good JA, Ziegler WH, Parekh DB et al. PKC isotypes controlled by PI3-kinase through the protein kinase PDK1. Science 1998; 281:2042–45.PubMedGoogle Scholar
  58. 58.
    Parekh D, Ziegler W, Yonezawa K et al. Mammalian TOR controls one of two kinase pathways acting upon nPKCd and nPKCe. J Biol Chem 1999; 274:34758–64.PubMedGoogle Scholar
  59. 59.
    Krieger-Brauer HI, Kather H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 1992; 89(3):1006–13.PubMedGoogle Scholar
  60. 60.
    Prasad RK, Ismail-Beigi F. Mechanism of stimulation of glucose transport by H2O2: Role of PLC. Arch Biochem Biophys 1999; 362(1):113–22.PubMedGoogle Scholar
  61. 61.
    Mahadev K, Wu X, Zilbering A et al. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 2001; 276(52):48662–69.PubMedGoogle Scholar
  62. 62.
    Mahadev K, Zilbering A, Zhu L et al. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001; 276(24):21938–42.PubMedGoogle Scholar
  63. 63.
    Heffetz D, Rutter WJ, Zick Y. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells. Biochem J 1992; 288(Pt 2):631–35.PubMedGoogle Scholar
  64. 64.
    Sutherland C, Tebbey PW, Granner DK. Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase, in hepatoma cells. Diabetes 1997; 46(1):17–22.PubMedGoogle Scholar
  65. 65.
    Morel Y, Barouki R. Repression of gene expression by oxidative stress. Biochem J 1999; 342:481–96.PubMedGoogle Scholar
  66. 66.
    Elchebly M, Payette P, Michaliszyn E et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1 B gene. Science 1999; 283(5407):1423–25.Google Scholar
  67. 67.
    Czechh MP. Lipid Rafts and insulin action. Nature 2000; 407:147–48.Google Scholar
  68. 68.
    Karin M. Signal transduction from the cell surface to the nucleus through the phosphory-lation of transcription factors. Curr Opin Cell Biol 1994; 6:415–24.PubMedGoogle Scholar
  69. 69.
    Angel P, Imagawa M, Chiu R et al. Phorbol ester-inducible genes contain a common cis element recognised by a TPA-modulated trans-acting factor. Cell 1987; 49:729–39.PubMedGoogle Scholar
  70. 70.
    Mohn KL, Laz TM, Melby AE et al. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. J Biol Chem 1990; 265:21914–21.PubMedGoogle Scholar
  71. 71.
    Chen R, Sarnecki C, Blenis J. Nuclear localisation and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol 1992; 12(3):915–27.PubMedGoogle Scholar
  72. 72.
    Deng T, Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 1994; 371(6493):171–75.PubMedGoogle Scholar
  73. 73.
    Morton S, Davis RJ, McLaren A et al. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003; 22(15):3876–86.PubMedGoogle Scholar
  74. 74.
    Denton RM, Tavare JM. Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against. Eur J Biochem 1995; 227(3):597–611.PubMedGoogle Scholar
  75. 75.
    Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin in Cell Biology 1996; 8:205–15.Google Scholar
  76. 76.
    Griffiths MR, Black EJ, Culbert AA et al. Insulin-stimulated expression of c-fos, fral and c-jun accompanies the activation of the activator protein-1 (AP-1) transcriptional complex. Biochem J 1998; 335(1):19–26.PubMedGoogle Scholar
  77. 77.
    Hurd TW, Culbert AA, Webster KJ et al. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation. Biochem J 2002; 368(2):573–80.PubMedGoogle Scholar
  78. 78.
    Lin K, Dorman JB, Rodan A et al. daf-16: An HNF3/forkhead family member that can function to double the life-span of C. elegans. Science 1997; 278:1319–22.PubMedGoogle Scholar
  79. 79.
    Ogg S, Paradis S, Gottlieb S et al. The forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C.elegans. Nature 1997; 389:994–99.PubMedGoogle Scholar
  80. 80.
    Biggs 3rd WH, Meisenhelder J, Hunter T et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 1999; 96(13):7421–6.PubMedGoogle Scholar
  81. 81.
    Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999; 96:857–68.PubMedGoogle Scholar
  82. 82.
    Kops GJPL, de Ruiter ND, De Vries-Smits AMM et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 1999; 398:630–34.PubMedGoogle Scholar
  83. 83.
    Rena G, Guo S, Cichy SC et al. Phosphorylation of the transcription factor forkhead family member FKHR by PKB. J Biol Chem 1999; 274(24):17179–83.PubMedGoogle Scholar
  84. 84.
    Tang ED, Nunez G, Barr FG et al. Negative regulation of the forkhead transcritpion factor FKHR by Akt. J Biol Chem 1999; 274(24):16741–46.PubMedGoogle Scholar
  85. 85.
    Rena G, Woods YL, Prescott AR et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 2002; 21(9):2263–71.PubMedGoogle Scholar
  86. 86.
    Guo S, Rena G, Cichy S et al. Phosphorylation of Ser 256 by PKB disrupts transactivation by FKHR and mediates effects of insulin on IGFBP-1 promoter activity through a conserved insulin response sequence. J Biol Chem 1999; 274(24):17184–92.PubMedGoogle Scholar
  87. 87.
    Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 2000; 19(5):989–96.PubMedGoogle Scholar
  88. 88.
    Hall RK, Yamasaki T, Kucera T et al. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The Role OF Winged Helix/Forkhead Proteins. J Biol Chem 2000; 275:30169–75.PubMedGoogle Scholar
  89. 89.
    Kops GJPL, Burgering BMT. Forkhead transcription factors: New insights into protein kinase B (c-akt) signaling. J Mol Med 1999; 77:656–65.PubMedGoogle Scholar
  90. 90.
    Woods YL, Rena G. Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX. Biochem Soc Trans 2002; 30(4):391–7.PubMedGoogle Scholar
  91. 91.
    Durham SK, Suwanichkul A, Scheimann AO et al. FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 1999; 140(7):3140–46.PubMedGoogle Scholar
  92. 92.
    Ayala JE, Streeper RS, Desgrosellier JS et al. Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: Transcription factor FKHR binds the insulin response sequence. Diabetes 1999; 48(9):1885–89.PubMedGoogle Scholar
  93. 93.
    Sudhof TC RD, Brown MS, Goldstein JL. 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter. Cell 1987; 48(6):1061–69.PubMedGoogle Scholar
  94. 94.
    Brown MS, Goldstein JL. Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake. Nutr Rev 1998; 56(2):S1–3.PubMedGoogle Scholar
  95. 95.
    Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 2002; 366(2):377–91.PubMedGoogle Scholar
  96. 96.
    Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109(9):1125–31.PubMedGoogle Scholar
  97. 97.
    Hua X, Yokoyama C, Wu J et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 1993; 90:11603–07.PubMedGoogle Scholar
  98. 98.
    Loewen CJ LT. Cholesterol homeostasis: Not until the SCAP lady INSIGs. Current Biology 2002; 12(22):R779–81.PubMedGoogle Scholar
  99. 99.
    Yabe D KR, Liang G, Goldstein JL et al. Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for fatty acid synthesis. Proc Natl Acad Sci USA 2003; 100(6):155–60.Google Scholar
  100. 100.
    Tontonoz P, Kim JB, Graves RA et al. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13:4753–59.PubMedGoogle Scholar
  101. 101.
    Kim JB SG, Halvorsen YD, Shih HM et al. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain. Mol Cell Biol 1995; 15(5):2582–88.PubMedGoogle Scholar
  102. 102.
    Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999; 274(42):30028–32.PubMedGoogle Scholar
  103. 103.
    Shimano H, Horton JD, Shimomura I et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997; 99(5):846–54.PubMedGoogle Scholar
  104. 104.
    Horton JD, Bashmakov Y, Shimomura I et al. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 1998; 95:5987–92.PubMedGoogle Scholar
  105. 105.
    Liang G, Yang J, Horton JD et al. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 2002; 277(11):9520–28.PubMedGoogle Scholar
  106. 106.
    Matsumoto M, Ogawa W, Teshigawara K et al. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 2002; 51(6):1672–80.PubMedGoogle Scholar
  107. 107.
    Roth G, Kotzka J, Kremer L et al. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 2000; 275(43):33302–07.PubMedGoogle Scholar
  108. 108.
    Giandomenico V SM, Gronroos E, Ericsson J. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol 2003; 23(7):2587–99.PubMedGoogle Scholar
  109. 109.
    Paulauskis JD, Sul HS. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J Biol Chem 1989; 264(1):574–77.PubMedGoogle Scholar
  110. 110.
    Latasa MJ, Griffin MJ, Moon YS et al. Occupancy and function of the −150 SRE and −65 E-box in nutritional rgulation of the FAS gene in living animals. Mol Cell Biol 2003; 16:5896–907.Google Scholar
  111. 111.
    Chakravarty K, Leahy P, Becard D et al. Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcripion. J Biol Chem 2001; 276(37):34816–23.PubMedGoogle Scholar
  112. 112.
    Becard D, Hainault I, Azzout-Marniche D et al. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 2001; 50(11):2425–30.PubMedGoogle Scholar
  113. 113.
    Suske G. The Sp-family of transcription factors. Gene 1999; 238(2):291–300.PubMedGoogle Scholar
  114. 114.
    Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 2002; 195:27–38.PubMedGoogle Scholar
  115. 115.
    Banfi C, Eriksson P, Giandomenico G et al. Transcriptional regulation of PAI-1 gene by insulin:insights into the signalling pathway. Diabetes 2001; 50(7):1522–30.PubMedGoogle Scholar
  116. 116.
    Murao K, Wada Y, Nakamura T et al. Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J Biol Chem 1998; 273(30):18959–65.PubMedGoogle Scholar
  117. 117.
    Samson SL, Wong NC. Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol 2002; 29(3):265–79.PubMedGoogle Scholar
  118. 118.
    Fry CJ, Farnham PJ. Context-dependent transcriptional regulation. J Biol Chem 1999; 274(42):29583–86.PubMedGoogle Scholar
  119. 119.
    Alexander M, Curtis G, Avruch J et al. Insulin regulation of protein biosynthesis in differentiated 3T3 adipocytes. J Biol Chem 1985; 260:11978–82.PubMedGoogle Scholar
  120. 120.
    Alexander MC, Lomanto M, Nasrin N et al. Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. Proc Natl Acad Sci USA 1988; 85:5092–95.PubMedGoogle Scholar
  121. 121.
    Nasrin N, Ercolani L, Denaro M et al. An insulin response element in the GAPDH gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc Natl Acad Sci 1990; 87:5273–77.PubMedGoogle Scholar
  122. 122.
    Zheng XL, Matsubara S, Diao C et al. Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J Biol Chem 2001; 276(17):13822–29.PubMedGoogle Scholar
  123. 123.
    Zheng XL, Matsubara S, Diao C et al. Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1. J Biol Chem 2000; 275(41):31747–54.PubMedGoogle Scholar
  124. 124.
    Pan X, Solomon S, Borromeo DM et al. Insulin deprivation leads to deficiency of Sp1 transcription factor in H-411E hepatoma cells and in streptozotocin-induced diabetic ketoacidosis in the rat. Endocrinology 2001; 142(4):1635–42.PubMedGoogle Scholar
  125. 125.
    Streeper RS, Chapman SC, Ayala JE et al. A phorbol ester-insensitive AP-1 motif mediates the stimulatory effect of insulin on rat malic enzyme gene transcription. Mol Endocrinol 1998; 12(11):1778–91.PubMedGoogle Scholar
  126. 126.
    Barroso I, Santisteban P. Insulin-induced early growth response gene (Egr-1) mediates a short term repression of rat malic enzyme gene transcription. J Biol Chem 1999; 274(25):17997–8004.PubMedGoogle Scholar
  127. 127.
    Messina JL. Insulin’s regulation of c-fos gene transcription in hepatoma cells. J Biol Chem 1990; 265:11700–05.PubMedGoogle Scholar
  128. 128.
    Burgering BM, Medema RH, Maassen JA et al. Insulin stimulation of gene expression mediated by p21ras activation. EMBO J 1991; 10:1103–09.PubMedGoogle Scholar
  129. 129.
    Medema RH, Wubbolts R, Bos JL. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression. Mol Cell Biol 1991; 11(12):5963–67.PubMedGoogle Scholar
  130. 130.
    Yamauchi K, Holt K, Pessin J. PI3-kinase functions upstream of ras and raf in mediating insulin stimulation of c-fos transcription. J Biol Chem 1993; 268(20):14597–600.PubMedGoogle Scholar
  131. 131.
    Stumpo DJ, Stewart TN, Gilman MZ et al. Identification of c-fos sequences involved in induction by insulin and phorbol esters. J Biol Chem 1988; 263(4):1611–14.PubMedGoogle Scholar
  132. 132.
    Treisman R. The Serum Response Element. TIBS 1992; 17:423–26.PubMedGoogle Scholar
  133. 133.
    Malik RK, Roe MW, Blackshear PJ. Epidermal growth factor and other mitogens, induce binding of a protein complex to the c-fos serum response element in human astrocytoma and other cells. J Biol Chem 1991; 266:8576–82.PubMedGoogle Scholar
  134. 134.
    Thompson MJ, Roe MW, Malik RK et al. Insulin and other growth factors induce binding of the ternary complex and a novel protein complex to the c-fos serum response element. J Biol Chem 1994; 269:21127–35.PubMedGoogle Scholar
  135. 135.
    Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992; 358:414–17.PubMedGoogle Scholar
  136. 136.
    Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993; 73:381–87.PubMedGoogle Scholar
  137. 137.
    Santisteban P, Kohn LD, Di Lauro R. Thyroglobulin gene expression is regulated by insulin and IGF-1, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem 1987; 262(9):4048–52.PubMedGoogle Scholar
  138. 138.
    Santisteban P, Acebron A, Polycarpou-Schwarz M et al. Insulin and IGFBP-1 regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinology 1992; 6:1310–17.Google Scholar
  139. 139.
    Ortiz L, Zannini M, Di Lauro R et al. Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and IGF-1. J Biol Chem 1997; 272(37):23334–39.PubMedGoogle Scholar
  140. 140.
    Aza-Blanc P, Di Lauro R, Santisteban P. Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. Mol Endocrinol 1993; 7(10):1297–306.PubMedGoogle Scholar
  141. 141.
    Ortiz L, Aza-Blanc P, Zannini M et al. The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 1999; 274(21):15213–21.PubMedGoogle Scholar
  142. 142.
    Francis-Lang H, Price M, Polycarpou-Schwarz M et al. Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol 1992; 12(2):576–88.PubMedGoogle Scholar
  143. 143.
    Zannini M, Avantaggiato V, Biffali E et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997; 16(11):3185–97.PubMedGoogle Scholar
  144. 144.
    Hanson RW, Reshef L. Regulation of PEPCK gene expression Annu Rev Biochem 1997; 66:581–611.PubMedGoogle Scholar
  145. 145.
    Sasaki K, Granner DK. Regulation of PEPCK gene transcription by insulin and cAMP: Reciprocal actions on initiation and elongation. Proc Natl Acad Sci 1988; 85:2954–58.PubMedGoogle Scholar
  146. 146.
    Imai E, Miner JN, Mitchell JA et al. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the PEPCK gene to glucocorticoids. J Biol Chem 1993; 268(8):5353–56.PubMedGoogle Scholar
  147. 147.
    ÓBrien RM, Printz RL, Halmi N et al. Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochem Biophys Acta 1995; 1264:284–88.Google Scholar
  148. 148.
    Wang J-C, Stromstedt P-E, ÓBrien RM et al. Hepatic Nuclear Factor 3 is an accessory factor required for the stimulation of PEPCK gene transcription by glucocorticoids. Mol Endo 1996; 10(7):794–800.Google Scholar
  149. 149.
    Scott DK, Mitchell JA, Granner DK. Identification and characterization of a second retinoic acid response element in the PEPCK gene promoter. J Biol Chem 1996; 271(11):6260–64.PubMedGoogle Scholar
  150. 150.
    Wang J-C, Stafford JM, Scott DK et al. The molecular physiology of HNF3 in the regulation of gluconeogenesis. J Biol Chem 2000; 275(19):14717–21.PubMedGoogle Scholar
  151. 151.
    Waltner-Law M, Duong DT, Daniesl MC et al. Elements of the glucocorticoid and retinoic acid response units are involved in cAMP-mediated expression of the PEPCK gene. J Biol Chem 2003; 278(12):10427–35.PubMedGoogle Scholar
  152. 152.
    Lucas PC, Granner DK. Hormone response domains in gene transcription. Ann Rev Biochem 1992; 61:1131–35.PubMedGoogle Scholar
  153. 153.
    ÓBrien RM, Lucas PC, Forest CD et al. Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science 1990; 249:533–37.Google Scholar
  154. 154.
    ÓBrien RM, Noisin EL, Suwanichkul A et al. HNF3 and hormone-regulated expression of the PEPCK and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 1995; 15(3):1747–58.Google Scholar
  155. 155.
    Nitsch D, Boshart M, Schutz G. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc Natl Acad Sci 1993; 90:5479–83.PubMedGoogle Scholar
  156. 156.
    Unterman TG, Fareeduddin A, Harris MA et al. HNF-3 binds to the insulin response sequence in the IGFBP-1 promoter and enhances promoter function. Biochem Biophys Res Comm 1994; 203(3):1835–41.PubMedGoogle Scholar
  157. 157.
    Faber S, ÓBrien RM, Imai E et al Dynamic aspects of DNA/protein interactions in the transcriptional initiation complex and the hormone-responsive domains of the PEPCK promoter in vivo. J Biol Chem 1993; 268(33):24796–85.Google Scholar
  158. 158.
    ÓBrien RM, Noisin EL, Granner DK. Comparison of the effects of insulin and okadaic acid on PEPCK gene expression. Biochem J 1994; 303:737–42.Google Scholar
  159. 159.
    Liao J, Barthel A, Nakatani K et al. Activation of PKB/Akt is sufficient to repress the glucocorticoid and cAMP induction of PEPCK gene. J Biol Chem 1998; 273(42):27320–24.PubMedGoogle Scholar
  160. 160.
    Lochhead PA, Coghlan MP, Rice SQJ et al. Inhibition of GSK3 selectively reduces G6Pase and PEPCK gene expression. Diabetes 2001; 50:937–47.PubMedGoogle Scholar
  161. 161.
    Duong DT, Waltner-Law ME, Sears R et al. Insulin inhibits hepatocellular glucose production by utilizing LIP to disrupt the association of CBP and RNA polymerase II with the PEPCK gene promoter. J Biol Chem 2002; 277(35):32234–42.PubMedGoogle Scholar
  162. 162.
    Lochhead PA, Salt IP, Walker KS et al. AICAR mimics the effects of insulin on the expression of 2 key gluconeogenic genes PEPCK and G6Pase. Diabetes 2000; 49(6):896–903.PubMedGoogle Scholar
  163. 163.
    Chu DTW, Granner DK. The effect of phorbol esters and diacylglycerols on expression of the PEPCK (GTP) gene in rat hepatoma H4IIE cells. J Biol Chem 1986; 261(36):16848–53.PubMedGoogle Scholar
  164. 164.
    Waltner-Law ME, Wang Xl, Law BK et al. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 2002; 277(38):34933–40.PubMedGoogle Scholar
  165. 165.
    Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20(6):761–87.PubMedGoogle Scholar
  166. 166.
    Lee PDK, Giudice LC, Conover CA et al. IGFBP-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997; 216:319–57.PubMedGoogle Scholar
  167. 167.
    Suwanichkul A, Morris SL, Powell DR. Identification of an IRE in the promoter of the human gene for IGFBP-1. J Biol Chem 1993; 268(23): 17063–68.Google Scholar
  168. 168.
    Goswami R, Lacson R, Yang E et al. Functional analysis of glucocorticoid and insulin response sequences in the rat IGFBP-1 promoter. Endocrinology 1994; 134(2):736–43.PubMedGoogle Scholar
  169. 169.
    Schweizer-Groyer G, Jibard N, Neau E et al. The glucocorticoid response element II is functionally homologous in rat and human insulin-like growth factor-binding protein-1 promoters. J Biol Chem 1999; 274(17):11679–86.PubMedGoogle Scholar
  170. 170.
    Suwanichkul A, Allander SV, Morris SL et al. Glucocorticoids and insulin regulate expression of the human gene for IGFBP-1 through proximal promoter elements. J Biol Chem 1994; 269(49):30835–41.PubMedGoogle Scholar
  171. 171.
    Mithieux G. New knowledge regarding glucose-6-phosphatase gene and protein and their roles in the regulation of glucose metabolism. Eur J Endocrin 1997; 136:137–45.Google Scholar
  172. 172.
    Foster JD, Pederson BA, Nordlie RC. Glucose-6-phosphatase structure, regulation, and function: An update. Proc Soc Exp Biol Med 1997; 215(4):314–32.PubMedGoogle Scholar
  173. 173.
    van de Werve G, Lange A, Newgard C et al. New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system. Eur J Biochem 2000; 267(6):1533–49.PubMedGoogle Scholar
  174. 174.
    Van Schaftingen E, Gerin I. The Glucose-6-Phosphatase System. Biochem J 2002; 362(3):513–32.PubMedGoogle Scholar
  175. 175.
    Chou JY, Matern D, Mansfield BC et al. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002; 2(2):121–43.PubMedGoogle Scholar
  176. 176.
    Efendic S, Karlander S, Vranic M. Mild type 2 diabetes markedly increases glucose cycling in the postabsorptive state during glucose infusion irrespective of obesity. J Clin Invest 1988; 81(6):1953–61.PubMedGoogle Scholar
  177. 177.
    Barzilai N, Rossetti L. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 1993; 268(33):25019–23.PubMedGoogle Scholar
  178. 178.
    Seoane J, Trinh K, O’Doherty RM et al. Metabolic impact of adenovirus-mediated overexpression of the G-6-Pase catalytic subunit in hepatocytes. J Biol Chem 1997; 272(43):26972–77.PubMedGoogle Scholar
  179. 179.
    Daniele N, Rajas F, Payrastre B et al. Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6-phosphatase during refeeding. J Biol Chem 1999; 274(6):3597–601.PubMedGoogle Scholar
  180. 180.
    Streeper RS, Svitek CA, Chapman S et al. A multicomponent IRS mediates a strong repression of mouse G-6-Pase gene transcription by insulin. J Biol Chem 1997; 272:11698–701.PubMedGoogle Scholar
  181. 181.
    Dickens M, Svitek CA, Culbert AA et al. Central Role for PI3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J Biol Chem 1998; 273:20144–49.PubMedGoogle Scholar
  182. 182.
    Streeper RS, Eaton EM, Ebert DH et al. HNF-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse G-6-Pase gene transcription. Proc Natl Acad Sci 1998; 95:9208–13.PubMedGoogle Scholar
  183. 183.
    Massillon D, Barzilai N, Chen W et al. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996; 271(17):9871–74.PubMedGoogle Scholar
  184. 184.
    Vander Kooi BT, Streeper RS, Svitek CA et al. The Three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct. J Biol Chem 2003, (published on-line as M212570200).Google Scholar
  185. 185.
    Ganss R, Weih F, Schutz G. The cAMP and the glucocorticoid dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription. Molec Endocrinology 1994; 8:895–903.Google Scholar
  186. 186.
    Nitsch D, Schutz G. The distal enhancer implicated in the developmental regulation of the tyrosine aminotransferase gene is bound by liver-specific and ubiquitous factors. Mol Cell Biol 1993; 13(8):4494–504.PubMedGoogle Scholar
  187. 187.
    Grange T, Cappabianca L, Flavin M et al. In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action. Oncogene 2003; 20(24):3028–38.Google Scholar
  188. 188.
    Carmichael D, Koontz J. Insulin-resonsive TAT transcription requires multiple promoter regions. Biochem Biophys Res Commun 1992; 187(2):778–82.PubMedGoogle Scholar
  189. 189.
    Rondinone CM, Carvalho E, Rahn T et al. Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor. J Biol Chem 2000; 275(14):10093–98.PubMedGoogle Scholar
  190. 190.
    Patel S, Lipina C, Sutherland C. Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response element. FEBS Lett 2003; 549:72–76.PubMedGoogle Scholar
  191. 191.
    Nakae J, Biggs WH, Kitamura T et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002; 32(2):245–53.PubMedGoogle Scholar
  192. 192.
    Band CJ, Posner BI. PI3-kinase and p70S6 kinase are required for insulin but not bisperoxovanadium 1,10-phenanthroline inhibition of IGFBP gene expression. J Biol Chem 1997; 272(1):138–45.PubMedGoogle Scholar
  193. 193.
    Patel S, Lochhead PA, Rena G et al. Insulin regulation of IGF-binding protein-1 gene expression is dependent on mammalian target of rapamycin (mTOR), but independent of S6K activity. J Biol Chem 2002; 277(12):9889–95.PubMedGoogle Scholar
  194. 194.
    Patel S, van der Kaay J, Sutherland C. Insulin regulation of IGFBP-1 gene expression is impaired by the presence of hydrogen peroxide due to a reduction in mTOR signalling. Biochem J 2002; 265(2):537–45.Google Scholar
  195. 195.
    Barthel A, Schmoll D, Kruger KD et al. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun 2001; 285(4):897–902.PubMedGoogle Scholar
  196. 196.
    Velho G, Froguel P. Maturity-onset diabetes of the young (MODY), MODY genes and NIDDM. Diabetes Metab 1997; 23(Suppl 2):34–37.PubMedGoogle Scholar
  197. 197.
    Yki-Jarvinen H. MODY genes and mutations in hepatocyte nuclear factors. Lancet 1997; 349:516–17.PubMedGoogle Scholar
  198. 198.
    Woodcroft KJ, Hafner MS, Novak RF. Insulin signalling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 2002; 35(2):263–73.PubMedGoogle Scholar
  199. 199.
    Au WS, Kung HF, Lin MC. Regulation of MTP gene by insulin in HepG2 cells: Roles of MAPK and p38MAPK. Diabetes 2003; 52(5):1073–80.PubMedGoogle Scholar
  200. 200.
    Miakotina OL, Goss KL, Snyder JM. Insulin utilises the PI s-kinase pathway to inhibit SP-A gene expression in lung epithelial cells. Respir Res 2002; 3(1):27.PubMedGoogle Scholar
  201. 201.
    Wang D, Sul H-S. Insulin stimulation of the fatty acid synthase promoter is mediated by the PI3-kinase pathway. J Biol Chem 1998; 273(39):25420–26.PubMedGoogle Scholar
  202. 202.
    Keeton AB, Amsler MO, Venable DY et al. Insulin signal transduction pathways and insulin-induced gene expression. J Biol Chem 2002; 277(50):48565–73.PubMedGoogle Scholar
  203. 203.
    Yamada K, Kawata H, Shou Z et al. Insulin induces the expression of the SHARP-2/Stra13/DEC1 gene via a PI3-kinase pathway. J Biol Chem 2003; Epub.Google Scholar
  204. 204.
    Osawa H, Sutherland C, Robey RB et al. Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin. J Biol Chem 1996; 271(28):16690–94.PubMedGoogle Scholar
  205. 205.
    Roques M, Vidal H. A phosphatidylinositol 3-kinase/p70 ribosomal S6 protein kinase pathway is required for the regulation by insulin of the p85 alpha regulatory subunit of phosphatidylinositol 3-kinase gene expression in human muscle cells. J Biol Chem 1999; 274(48):34005–10.PubMedGoogle Scholar
  206. 206.
    Buyse M, Veingchareun S, Bado A et al. Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. FASEB J 2001; 15(8):1357–66.PubMedGoogle Scholar
  207. 207.
    Hayakawa J, Ohmichi M, Tasaka K et al. Regulation of the PRL promoter by Akt through cAMP response element binding protein. Endocrinology 2002; 143(1):13–22.PubMedGoogle Scholar
  208. 208.
    Teruel T, Valverde AM, Navarro P et al. Inhibition of PI3-kinase and Ras blocks IGF-1 and insulin-induced UCP1 gene expression in brown adipocytes. J Cell Physiol 1998; 176(1):99–109.PubMedGoogle Scholar
  209. 209.
    Leibiger B, Leibiger IB, Moede T et al. Selective insulin signalling through A and B insulin receptors regulates trancription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7(3):559–70.PubMedGoogle Scholar
  210. 210.
    Kremerskothen J, Wendholt D, Teber I et al. Insulin-induced expression of the activity-regulated cytoskeleton-associated gene (ARC) in human neuroblastoma cells requires p21(ras), MAP kinase and src tyrosine kinases but is PKC-independent. Neurosci Lett 2002; 321(3):153–56.PubMedGoogle Scholar
  211. 211.
    Iida KT, Shimano H, Kawakami Y et al. Insulin up-regulates TNF-alpha production in macrophages through an erk-dependent pathway. J Biol Chem 2001; 276(35):32531–37.PubMedGoogle Scholar
  212. 212.
    Meile C, Rochford JJ, Filippa N et al. Insulin and IGF-1 induce vEGF mRNA expression via different signalling pathways. J Biol Chem 2000; 275(28):21695–702.Google Scholar
  213. 213.
    Sekar N, Veldhuis JD. Concerted transcriptional activation of the ldl receptor gene by insulin and LH in cultured porcine granulosa-luteal cells. Endocrinology 2001; 142(7):2921–28.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2007

Authors and Affiliations

  • Calum Sutherland
  • Richard M. O’ Brien
  • Daryl K. Granner
    • 1
  1. 1.Department of Molecular Physiology and BiophysicsVanderbilt University Medical SchoolNashvilleUSA

Personalised recommendations